Arcosa vs Valmont Industries
ACA and VMI side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACA and VMI compare
Arcosa and Valmont Industries are about the same size, with market caps of $7.3B and $8.1B.
On earnings, Arcosa is cheaper: it trades at 14.9× trailing earnings, against 17.3× for Valmont Industries.
Arcosa grew revenue faster over the last twelve months (9.7% versus 3.8% for Valmont Industries).
Arcosa keeps more of each dollar of sales as profit, with a net margin of 17.9% compared with 11.7% at Valmont Industries.
Both pay dividends: Arcosa yields 0.13% and Valmont Industries 0.71%.
Valmont Industries scores higher on the StockData Score (20 against 17 for Arcosa), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACA | VMI |
|---|---|---|
| Size and price | ||
| Market cap | $7.3B | $8.1B |
| Share price | $149.03 | $422.10 |
| Change, 1 year | 59.1% | 0.68% |
| Change, 5 years | 188% | 66.8% |
| Beta (5Y) | 1.03 | 0.95 |
| Employees | 6,390 | 6,294 |
| StockData Score | ||
| Total score | 17 | 20 (better) |
| Valuation score | 4 | 4 |
| Growth score | 2 | 2 |
| Performance score | 4 | 5 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 14.9× (better) | 17.3× |
| P/S | 2.7× | 1.9× (better) |
| P/B | 2.5× (better) | 4.7× |
| EV/EBITDA | 15.2× | 13.0× (better) |
| P/FCF | 54.1× | 25.3× (better) |
| PEG | – | 1.33 |
| FCF yield | 1.8% | 4.0% (better) |
| Fair value | $191.44 | $477.72 |
| Margin of safety | 22.2% (better) | 11.6% |
| Growth | ||
| Revenue growth (TTM) | 9.7% (better) | 3.8% |
| Revenue growth, 5Y average | 8.3% (better) | 7.2% |
| Net income growth (TTM) | 433% (better) | 103% |
| EPS growth (TTM) | 431% (better) | 127% |
| EPS growth, 5Y average | 14.2% | 20.6% (better) |
| Profitability | ||
| Gross margin | 23.0% | 30.4% (better) |
| Operating margin | 11.8% | 13.7% (better) |
| Net margin | 17.9% (better) | 11.7% |
| FCF margin | 4.9% | 7.6% (better) |
| Return on equity | 17.9% | 30.4% (better) |
| Return on invested capital | 7.0% | 24.1% (better) |
| Financial health | ||
| Debt / equity | 0.48 | 0.42 (better) |
| Net debt / EBITDA | 1.83 | 0.88 (better) |
| Interest coverage | 3.3× | 15.0× (better) |
| Current ratio | 3.12 (better) | 2.35 |
| Altman Z-score | 3.17 | 6.31 (better) |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 0.13% | 0.71% (better) |
| Payout ratio | 2.0% | 11.1% |
| Years of dividend growth | 0 | 1 (better) |
| Dividend growth, 5Y average | 0.00% | 8.6% (better) |
| Buyback yield | – | 2.6% |
| Shareholder yield | 0.13% | 3.4% (better) |
| Ownership | ||
| Held by institutions | 92.0% | 95.1% |
| Held by insiders | 1.9% | 1.5% |
| Insider net buying, 12 months | – | −$9.3M |
| Short interest, % of float | – | 2.2% |
Go deeper
- ACA stock overview
- ACA income statement
- ACA valuation and score
- VMI stock overview
- VMI income statement
- VMI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.